The DEFA14A itself is non-material — watch for the preliminary proxy statement (Schedule 14A) which will disclose the merger exchange ratio, pro-forma financials, and shareholder vote mechanics. The stock is an SPAC-like binary event: either the merger closes and HSCS becomes a crypto miner, or it fails and the medical device company likely faces continued cash burn. Narrow trading range likely until the proxy is filed.
Price Chart
Executive Summary
HeartSciences (HSCS) filed additional definitive proxy soliciting materials (DEFA14A) containing a social media post from a Fortitude Mining Holdings executive in support of the all-stock merger agreement announced June 23, 2026. The filing is routine procedural solicitation — no new financial terms or vote outcomes are disclosed. The merger transforms HSCS from an AI-medical-device company into a Zcash mining platform, with the combined entity likely retaining the Nasdaq listing under a new name and ticker.
Key Financial Metrics
Key Facts
- DEFA14A filed June 26, 2026 as additional soliciting material for the proposed all-stock merger with Fortitude Mining Holdings.
- The filing contains a social media post by a Fortitude executive — no new financial terms, offer price, or shareholder vote results.
- Definitive merger agreement was filed June 23 (3 days prior) in an 8-K; this DEFA14A is a routine follow-up solicitation.
- HeartSciences will file a preliminary proxy statement on Schedule 14A; date of shareholder special meeting not yet set.
- Combined company will be a vertically-integrated digital asset mining platform anchored in Zcash, dropping the medical-device business.
Financial Impact
No financial figures disclosed in this filing. All-stock merger with Fortitude — deal value not stated. HSCS market cap ~$10M.
Risk Factors
- Merger may not close — requires shareholder approval and regulatory clearances.
- Zcash / crypto price volatility could render the combined company's economics highly uncertain.
- Medical device business has no disclosed path to profitability; current analyst consensus (88% bullish) may be irrelevant post-merger.
- Micro-cap stock ($10M market cap) with large insider grant (425,000 shares to Andrew Simpson) creates potential dilution risk for minority holders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-072662 |
| Document: 0001213900-26-072662-index-headers.html | 0001213900-26-072662 |
| Document: 0001213900-26-072662-index.html | 0001213900-26-072662 |
| Document: 0001213900-26-072662.txt | 0001213900-26-072662 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | DEFA14A | — | awaiting T+1 | — | — |
Oct 23, 2026 2d ago | SC 13D/A | $3.41 | awaiting T+1 | — | $3.18 (−6.74%) |
Oct 21, 2026 5d ago | DEFA14A | $3.17 $3.14 | ▼ −0.95% | ▼ −0.42% | $3.18 (+0.32%) |
Oct 19, 2026 7d ago | DEFA14A | $3.13 $3.56 | ▲ +13.74% | ▲ +13.21% | $3.18 (+1.60%) |
Oct 19, 2026 7d ago | DEFA14A | $3.07 $3.13 | ▲ +1.95% | ▲ +1.62% | $3.18 (+3.58%) |
Oct 19, 2026 7d ago | DEFM14A | $3.07 $3.13 | ▼ −1.95% | ▼ −1.62% | $3.18 (−3.58%) |
Oct 15, 2026 10d ago | DEFA14A | $3.02 $3.07 | ▲ +1.66% | ▲ +1.23% | $3.18 (+5.30%) |
Oct 9, 2026 16d ago | 424B5 | $3.30 $3.09 | ▲ +6.36% | ▲ +6.35% | $3.18 (+3.64%) |
Oct 6, 2026 20d ago | DEFA14A | $3.49 $3.04 | ▼ −12.89% | ▼ −12.47% | $3.18 (−8.88%) |
Oct 6, 2026 20d ago | 8-K | $3.49 $3.04 | ▼ −12.89% | ▼ −12.47% | $3.18 (−8.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers